Menu
Live
Market Overview
Live indices, gainers & losers
Market Pulse
AI-curated live updates
Market Movers
Top gainers & losers by cap
Market Signals
Value, momentum & analyst signals
Smart Money
Insider & congress trades
Hedge Funds
What 63 elite funds bought & sold
52-Week Highs
Stocks breaking out to new highs
52-Week Lows
Beaten-down stocks near support
High Beta
Stocks that move more than the market
Earnings Calendar
Upcoming earnings dates
Daily
Research
Invest
LIVE
LifeStance Health Group, Inc.
LFST
NASDAQ·Healthcare·Medical - Care Facilities·Mkt cap $4.4B
$11.27
▼ -1.40%
View full research view
Our plain-language verdict, the thesis, risk factors, and what is changing about the business.
View research view52-Week Range
$3.74 - $11.62
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 139.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Omnichannel delivery model combining telehealth and physical centers across 32 states
- Comprehensive service suite reducing patient referrals and increasing care continuity
- Scalable technology platform enabling rapid geographic and service expansion
- Established relationships with insurance providers and employer health plans
Bear Case
2 risks
- Average volatility.
- Extreme premium - high expectations embedded
Growth
Moderate growth ahead
Rising mental health awareness and destigmatization driving patient demand
Value
Extreme premium - high expectations embedded
Momentum
Hot
+81.1% over 3m
Quality
Stable
Exceptional business - top-tier fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying LFST right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: May 6, 2026
MAY 7, 2026
Reported EPS of $0.04 vs $0.01 consensus (+300.0% surprise). Revenue of $403.5M vs $387.5M expected (+4.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Q2 26
+300.0%
Next: May 6, 2026
Revenue trend · last 8Q
—
—
+16%
+11%
+11%
+16%
+17%
+21%
Q2 24
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
$312.3M
$312.7M
$325.5M
$333.0M
$345.3M
$363.8M
$382.2M
$403.5M
Margins · last 8Q
Gross
—
Operating
—
Profit
3.5%
Wall Street consensus
7 analysts · 71% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
71%
Hold
29%
Sell
0%
Median Price Target
$11.00
▼ -2.4% vs $11.27
Latest: Goldman Sachs · Jun 5, 2026
1 analyst covering
vs Industry
How LFST stacks vs Medical - Care Facilities
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related